4.2 Pigmentation Disorders, Vascular Conditions & Skin Cancers

Pigmentation Disorders, Vascular Conditions & Skin Cancers

Exam Focus: Master the biological mechanisms distinguishing melasma (hormonal, symmetrical, exacerbated by UV and heat), solar lentigines (age spots from chronic UV), and Post-Inflammatory Hyperpigmentation (PIH) (melanin response to trauma, highest in Fitzpatrick IV–VI). Understand hypopigmentation: vitiligo (autoimmune melanocyte destruction), albinism (congenital tyrosinase absence), and tinea versicolor (Malassezia fungal inhibition). Recognize vascular conditions like telangiectasias (couperose skin) and enforce treatment modifications (no hot steam, no harsh friction). Memorize the three skin cancers: Basal Cell Carcinoma (BCC) (pearly rolled borders, telangiectasias, most common, rarely metastasizes), Squamous Cell Carcinoma (SCC) (scaly, crusted, indurated ulcer), and Malignant Melanoma (deadliest, rapid metastasis). Memorize all five ABCDE criteria for melanoma.

---

Cutaneous Dyschromias: Pigmentation Pathophysiology

A dyschromia is defined as any abnormal coloration of the skin, categorized pathophysiologically into hyperpigmentation (excess melanin production and deposition) or hypopigmentation / depigmentation (deficiency or total absence of melanin).

The Melanogenesis Cascade (Review)

Melanin is synthesized within dendritic melanocytes located in the stratum basale. Inside membrane-bound organelles called melanosomes, the copper-containing enzyme tyrosinase oxidizes the amino acid L-tyrosine into dihydroxyphenylalanine (L-DOPA), and subsequently into dopaquinone. Melanin is synthesized as either photoprotective, dark-brown/black eumelanin or sulfur-rich, yellow/red pheomelanin. Dendritic processes transfer these mature pigment granules to approximately 30 to 36 surrounding keratinocytes, forming an epidermal melanin unit where melanosomes arrange in a protective "supranuclear cap" to shield cellular DNA from ultraviolet radiation.

[ L-Tyrosine ] ──(Tyrosinase Enzyme)──▶ [ L-DOPA ] ──▶ [ Dopaquinone ]
                                                            │
                        ┌───────────────────────────────────┴─────────────────┐
                        ▼                                                     ▼
               [ Eumelanin ]                                         [ Pheomelanin ]
        (Dark Brown / Black; UV-Shielding)                    (Yellow / Red; Free Radical Generating)

---

Hyperpigmentation Disorders

Hyperpigmentation occurs when melanocytes are stimulated by endocrine hormones, inflammatory cytokines, or ultraviolet radiation to produce excess melanin, or when melanocytes abnormally proliferate.

1. Melasma (Chloasma / "The Mask of Pregnancy")

Melasma is an acquired, chronic pigmentary disorder characterized by symmetrical, reticulated, geographic macules and patches of light-to-dark brown hyperpigmentation on the face. It typically affects the central forehead, malar cheeks, bridge of the nose, chin, and upper cutaneous lip.

• Etiological Factors: Melasma is driven primarily by endocrine hormonal surges (specifically elevated estrogen and progesterone levels during pregnancy, oral contraceptive usage, or hormone replacement therapy) interacting with genetic predisposition. When melasma occurs during pregnancy, it is historically termed chloasma.
• The Critical Esthetic Factor: Melasma melanocytes are pathologically hyperactive and hypersensitive. They are stimulated not only by ultraviolet radiation (UV-A and UV-B) but also by infrared heat and visible light. Aggressive esthetic treatments that generate significant friction, mechanical drag, or high thermal heat (such as hot facial steam, intense microdermabrasion, or high-heat lasers) trigger inflammatory cascades that severely worsen melasma! Esthetic treatment requires gentle, non-thermal exfoliation (e.g., mandelic acid, lactic acid), daily physical broad-spectrum mineral sunscreen (zinc oxide/titanium dioxide), and topical tyrosinase inhibitors (kojic acid, arbutin, azelaic acid, L-ascorbic acid, tranexamic acid).

2. Solar Lentigines (Actinic Lentigines / "Liver Spots" / "Age Spots")

Solar lentigines (singular: lentigo) are discrete, circumscribed, flat, uniformly pigmented tan-to-dark brown macules appearing on anatomical surfaces subjected to cumulative, long-term ultraviolet radiation (face, dorsa of the hands, forearms, shoulders, and décolleté).

• Pathophysiology: Unlike simple freckles, solar lentigines are caused by an actual localized proliferation of melanocytes and elongated epidermal rete pegs at the dermal-epidermal junction. They do not fade completely during winter months. While benign, they serve as a definitive clinical marker of extensive photo-damage and increased lifetime risk for skin cancer.

3. Post-Inflammatory Hyperpigmentation (PIH)

Post-inflammatory hyperpigmentation (PIH) presents as flat macules or patches of excess pigmentation that develop at the exact anatomical site of a previous inflammatory cutaneous event, physical trauma, or chemical injury (such as excoriated acne lesions, allergic contact dermatitis, chemical burns, aggressive laser treatments, or poorly performed manual extractions).

• Cellular Mechanism: During cutaneous inflammation, inflammatory mediators (prostaglandins, leukotrienes, interleukins) stimulate basal melanocytes to accelerate melanogenesis. Melanin can either accumulate within epidermal keratinocytes (epidermal PIH, which appears tan or brown and responds well to topical exfoliation) or fall through a breached basement membrane into the papillary dermis (dermal PIH, which appears slate-gray or blue-brown and is engulfed by dermal macrophages called melanophages, taking months to years to resolve).
• Demographic Vulnerability: PIH occurs with significantly higher incidence, intensity, and persistence in clients with darker Fitzpatrick Skin Phototypes IV, V, and VI. In these phototypes, the melanocytes are highly reactive; any aggressive, overly acidic, or thermally traumatic esthetic service can induce disfiguring hyperpigmentation.

4. Ephelides (Freckles)

Ephelides (singular: ephelis) are small (1 to 2 mm), flat, pale-to-medium brown macules that appear on sun-exposed skin in genetically susceptible individuals (predominantly Fitzpatrick types I and II with red or blonde hair, linked to the MC1R gene). Crucially, individuals with ephelides possess a normal number of melanocytes; however, those melanocytes produce increased quantities of pheomelanin upon UV exposure. Freckles darken prominently during summer months and fade significantly or disappear entirely during winter.

5. Nevus (Mole)

A nevus (plural: nevi) is a benign, circumscribed cutaneous lesion composed of nests or clusters of melanocytes (nevus cells). Nevi can be congenital (present at birth) or acquired throughout life. They range from flat, smooth macules (junctional nevi) to raised, dome-shaped, pigmented or flesh-toned papules (intradermal nevi). While common nevi are benign, any changing, asymmetrical, or multi-colored nevus must be evaluated for malignant melanoma.

---

Hypopigmentation and Depigmentation Disorders

┌────────────────────────────────────────────────────────────────────────┐
│                     HYPOPIGMENTATION DISORDERS                         │
├─────────────────────┬───────────────────┬──────────────────────────────┤
│ Condition           │ Etiological Cause │ Clinical Presentation        │
├─────────────────────┼───────────────────┼──────────────────────────────┤
│ Vitiligo            │ Autoimmune T-cell │ Sharply demarcated, chalk-   │
│                     │ attack on melanos │ white smooth depigmented     │
├─────────────────────┼───────────────────┼──────────────────────────────┤
│ Albinism            │ Congenital gene   │ Complete lack of melanin in  │
│                     │ defect (no tyros) │ skin, hair, and irises       │
├─────────────────────┼───────────────────┼──────────────────────────────┤
│ Leukoderma          │ Post-traumatic    │ Localized acquired loss of   │
│                     │ destruction       │ pigment following deep burns │
├─────────────────────┼───────────────────┼──────────────────────────────┤
│ Tinea Versicolor    │ Malassezia fungal │ Scaly, discolored patches on │
│                     │ azelaic inhibit   │ trunk; fungal infection      │
└─────────────────────┴───────────────────┴──────────────────────────────┘

• Vitiligo: An acquired, progressive autoimmune disorder in which cytotoxic CD8+ T-lymphocytes attack and destroy epidermal melanocytes. It presents as sharply demarcated, stark chalk-white or ivory depigmented patches (completely devoid of melanin) surrounded by normal skin. Common sites include the periorbital and perioral areas, hands, wrists, elbows, and knees. Vitiligo patches lack natural photoprotection and burn severely under UV radiation. Estheticians must never attempt aggressive chemical peeling on vitiligo patches, but may provide cosmetic corrective camouflage makeup.
• Albinism: A rare, congenital, hereditary autosomal recessive disorder characterized by a complete or near-total absence of melanin pigment in the skin, hair, and eyes. It is caused by an inherited genetic mutation that inactivates the tyrosinase enzyme. Individuals with albinism have pale white skin, white or light blonde hair, and pink or light blue irises. They have zero natural defense against solar radiation, experience extreme photophobia, and possess a catastrophic lifetime risk of UV-induced skin cancers. Broad-spectrum SPF 50+ is mandatory for any sun exposure.
• Leukoderma: A generalized descriptive term meaning "white skin," referring to an acquired, localized loss of cutaneous pigmentation occurring secondary to deep physical trauma, severe chemical burns, cryotherapy, or severe inflammatory dermatoses. In leukoderma, the basal melanocytes were destroyed during the original tissue trauma.
• Tinea Versicolor (Pityriasis Versicolor): A superficial, non-contagious fungal infection of the stratum corneum caused by an overgrowth of lipophilic yeasts of the genus Malassezia (primarily Malassezia globosa and Malassezia furfur). The yeast secretes azelaic acid and other dicarboxylic acid metabolites that act as competitive inhibitors of the tyrosinase enzyme, while exerting direct cytotoxic effects on melanocytes. This results in patchy, finely scaling, hypopigmented (or sometimes hyperpigmented/pink) macules and patches located predominantly on the chest, back, neck, and upper arms. It fluoresces pale yellow-green or copper-orange under a Wood's lamp. Estheticians must refer clients displaying tinea versicolor to a physician for topical antifungal treatment.

---

Vascular Conditions and Clinical Esthetic Protocol Modifications

Cutaneous vascular lesions arise from structural weakness, pathological dilation, or abnormal proliferation of dermal blood vessels. Understanding vascular fragility prevents estheticians from exacerbating conditions in the treatment room.

1. Telangiectasia (Couperose Skin)

Telangiectasias (commonly referred to in clinical esthetics as couperose skin or colloquially as "broken capillaries") are permanently dilated, distended superficial capillaries, arterioles, and venules measuring 0.1 mm to 1.0 mm in diameter, situated in the upper papillary dermis.

• Clinical Presentation: Appear as fine, delicate, bright red, purple, or bluish thread-like, spider-web-like lines that blanch (turn white momentarily) when pressed under a clear glass spatula (diascopy). They are most prominent on the nasal ala, cheeks, and chin.
• Pathophysiological Causes: Microvascular walls lose their natural muscular elasticity due to chronic sun damage (UV breakdown of supporting collagen), extreme temperature fluctuations (freezing wind to hot indoor heating), excessive alcohol intake, harsh mechanical scrubs, pregnancy hormones, genetic vessel wall weakness, and rosacea.

Protocol Modifications for Telangiectatic / Couperose Skin:

• Eliminate Thermal Shock: Do NOT use hot facial towels, boiling steam placed close to the face, or saunas. Use lukewarm or cool water exclusively.
• Avoid Aggressive Mechanical Exfoliation: Strictly avoid gritty abrasive physical scrubs, rotating mechanical facial brushes, and crystal microdermabrasion. Opt instead for gentle enzyme peels or very mild polyhydroxy acids (PHAs).
• Eliminate High-Suction Modalities: Vacuum suction devices must never be dragged across couperose zones, as negative pressure easily ruptures fragile capillary walls, causing purpura and petechiae.
• Modify Massage Manipulations: Avoid heavy petrissage, deep friction, and rapid tapotement on affected areas. Perform only ultra-gentle, soothing effleurage and manual lymphatic drainage (MLD).
• Calming Active Ingredients: Utilize calming, vasoconstrictive, and anti-inflammatory botanicals such as horse chestnut, butcher's broom, arnica, bisabolol, chamomile, and centella asiatica.

2. Cherry Angioma

A cherry angioma is a small (1 to 5 mm), smooth, bright ruby-red or violaceous, dome-shaped vascular papule resulting from a benign proliferation of blood vessels (vascular endothelial hyperplasia) in the papillary dermis. They are harmless, non-contagious, asymptomatic, and appear with increasing frequency after age 30. Estheticians must avoid aggressive friction over cherry angiomas to prevent bleeding.

3. Port-Wine Stain (Nevus Flammeus)

A port-wine stain is a congenital vascular malformation of superficial dermal capillaries that presents at birth as a large, flat, irregular, dark red or deep purple patch, most frequently located on one side of the face or neck. Unlike infantile hemangiomas, port-wine stains do not involute or fade with age; they grow proportionally with the individual and may become thickened, dark, and nodular in adulthood. The medical gold-standard treatment is pulsed-dye laser therapy.

---

Pre-Cancerous Lesions & Cutaneous Malignancies

Skin cancer is the most commonly diagnosed cancer in the United States. Because estheticians examine the client's skin under direct, illuminated magnification during every professional treatment, they hold an essential responsibility to recognize suspicious lesions and protect clients through immediate medical referral.

┌────────────────────────────────────────────────────────────────────────┐
│                     SPECTRUM OF CUTANEOUS MALIGNANCIES                 │
├─────────────────────────┬──────────────────────┬───────────────────────┤
│ Lesion Type             │ Cellular Origin      │ Clinical Hallmarks    │
├─────────────────────────┼──────────────────────┼───────────────────────┤
│ Actinic Keratosis       │ Epidermal keratinos  │ Rough, sandpaper      │
│ (Precancerous)          │ (Stratum spinosum)   │ scale; UV-damaged     │
├─────────────────────────┼──────────────────────┼───────────────────────┤
│ Basal Cell Carcinoma    │ Basal stem cells     │ Pearly rolled border, │
│ (Most Common, ~80%)     │ (Stratum basale)     │ telangiectasias       │
├─────────────────────────┼──────────────────────┼───────────────────────┤
│ Squamous Cell Carcinoma │ Squamous keratino-   │ Firm, crusted red     │
│ (Second Most, ~20%)     │ cytes (Spinosum)     │ papule; open ulcer    │
├─────────────────────────┼──────────────────────┼───────────────────────┤
│ Malignant Melanoma      │ Melanocytes          │ Asymmetrical, uneven  │
│ (Deadliest, ~1%)        │ (Neural crest origin)│ colors, rapid spread  │
└─────────────────────────┴──────────────────────┴───────────────────────┘

1. Actinic Keratosis (AK) — The Pre-Cancerous Lesion

Actinic keratosis (also termed solar keratosis) is a localized pre-malignant (precancerous) epidermal lesion caused by chronic, cumulative ultraviolet radiation damage.

• Clinical Presentation: Presents as a rough, gritty, sandpaper-textured, dry, scaly or crusted patch or flat papule ranging from 2 mm to 6 mm in size. It is often flesh-colored, pink, reddish, or yellowish-brown. In many instances, an actinic keratosis is felt before it is seen—the esthetician detects a persistent rough patch upon tactile palpation during skin analysis.
• Malignant Transformation: Actinic keratosis arises from atypical dysplasia of basal and squamous keratinocytes. Upwards of 10% of untreated actinic keratoses undergo malignant transformation into invasive Squamous Cell Carcinoma (SCC). Estheticians must never attempt to scrape, peel, or exfoliate an actinic keratosis; immediate referral to a dermatologist for cryotherapy (liquid nitrogen) or topical chemotherapeutic agents (e.g., 5-fluorouracil) is required.

2. Basal Cell Carcinoma (BCC)

Basal cell carcinoma is the most common form of skin cancer, accounting for approximately 80% of all diagnosed cutaneous malignancies. It arises from the mitotically active pluripotential stem cells of the stratum basale.

• Biological Behavior: BCC is slow-growing and locally invasive. Metastasis to distant organs is exceedingly rare (<0.1%); however, if neglected, a BCC will relentlessly invade and destroy underlying dermal structures, subcutaneous fat, cartilage, and bone, producing severe local disfigurement.
• Clinical Appearance: The classic nodular BCC presents as a smooth, shiny, pearly or translucent dome-shaped bump with distinctive rolled, elevated borders. Fine, branching surface telangiectasias (spider veins) are typically visible traversing the lesion. In later stages, the center develops an indentation, ulcerates, bleeds easily upon light contact, scabs over, and repeatedly fails to heal (the classic "sore that will not heal").

3. Squamous Cell Carcinoma (SCC)

Squamous cell carcinoma is the second most common form of skin cancer, accounting for roughly 20% of non-melanoma skin cancers. It arises from the malignant transformation of keratinocytes in the stratum spinosum.

• Biological Behavior: SCC is significantly more aggressive than basal cell carcinoma. It has a notable propensity for metastasis to regional lymph nodes and distant internal organs, particularly when developing on mucosal junctions (such as the lower lip, ears, or mucous membranes).
• Clinical Appearance: Presents as a firm, indurated (hardened), red or flesh-toned papule, plaque, or crusted nodule with rough, adherent hyperkeratotic scales. As it progresses, it frequently forms a persistent, non-healing, crater-like open ulcer with an elevated, firm, inflamed border that bleeds easily. It commonly arises from a pre-existing actinic keratosis on sun-exposed zones (scalp of bald men, ears, face, hands).

4. Malignant Melanoma — The Deadliest Skin Cancer

Malignant melanoma is the most dangerous and lethal form of cutaneous neoplasm, responsible for the vast majority of skin cancer-related mortalities worldwide. It originates from the malignant transformation of melanocytes.

• Biological Behavior: Melanoma has an extraordinary capacity for early vertical invasion into the rich vascular and lymphatic beds of the dermis, resulting in rapid hematogenous and lymphatic metastasis to vital organs (lungs, liver, brain, bone). When diagnosed and surgically excised early (while strictly confined to the epidermis—melanoma in situ), survival rates exceed 95%; once deep vertical invasion and distant metastasis occur, the prognosis drops precipitously.
• Anatomical Distribution: Melanoma can develop de novo (arising spontaneously on previously clear, normal skin in roughly 70% to 80% of cases) or within a pre-existing melanocytic nevus (in 20% to 30% of cases). In women, the most common anatomical site is the lower legs; in men, the most common site is the upper back and trunk. In darker skin phototypes, it frequently develops in non-sun-exposed regions such as the soles of the feet, palms of the hands, or under nail beds (acral lentiginous melanoma).

---

The ABCDE Criteria for Early Melanoma Detection

To standardize cutaneous screening, the American Academy of Dermatology formulated the ABCDE criteria—a universally recognized clinical framework for differentiating benign nevi from early malignant melanoma:

┌────────────────────────────────────────────────────────────────────────┐
│                     ABCDE MELANOMA CRITERIA QUICK-SCAN                 │
├────────────────────────────────────────────────────────────────────────┤
│  [A] ASYMMETRY        ── Left half does not mirror right half          │
│  [B] BORDER           ── Notched, ragged, blurred, or scalloped edge   │
│  [C] COLOR            ── Multiple shades: black, brown, red, white     │
│  [D] DIAMETER         ── Exceeds 6 mm (standard pencil eraser)         │
│  [E] EVOLVING         ── Changes in size, elevation, bleeding, itching │
└────────────────────────────────────────────────────────────────────────┘

Professional Protocol for Suspicious Lesions

If an esthetician observes any lesion meeting one or more of the ABCDE criteria:

1. Never Touch or Manipulate: Do not perform extractions, chemical peels, microdermabrasion, waxing, or mechanical brushing over or around the lesion.
2. Never Attempt Diagnosis: It is illegal and unethical for an esthetician to state, "You have skin cancer." Instead, state professionally and objectively: "I noticed an irregular mole on your cheek that has asymmetric borders and multiple colors. As a licensed esthetician, I always recommend having any changing or atypical spots evaluated by a board-certified dermatologist."
3. Chart Objectively: Document the anatomical location, size, and visual characteristics in the client's confidential record.
4. Refuse Treatment if Necessary: If a lesion is ulcerated, actively bleeding, or rapidly changing, postpone the treatment until medical clearance is obtained.